Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia
Gemma Llovera(LMU Klinikum), Arthur Liesz(LMU Klinikum), Uta Mamrak(LMU Klinikum), André Rex(Charité - Universitätsmedizin Berlin), Claudine Fauchon(Université de Caen Normandie), Cyrille Orset(Inserm), Stefan Roth(LMU Klinikum), Elisa R. Zanier(Mario Negri Institute for Pharmacological Research), Maria Grazia De Simoni(Istituto di Fisiologia Clinica), Carlo Perego(Mario Negri Institute for Pharmacological Research), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Angélica Salas-Perdomo(Institut d'Investigacions Biomèdiques de Barcelona), Nikolaus Plesnila(Stroke Association), Maura Ferrer-Ferrer(Institut d'Investigacions Biomèdiques de Barcelona), Anna M. Planas(Consejo Superior de Investigaciones Científicas), Véronique Agin(Inserm), Ulrike Grittner(Charité - Universitätsmedizin Berlin), Hélène Party(Inserm), Denis Vivien(Centre Hospitalier Universitaire de Caen Normandie), Benoît Haelewyn(Inserm), Kerstin Hofmann(LMU Klinikum)
Cited by 257
Related Papers
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke
|Journal of Neuroscience|2016|764
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|601
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
|The Lancet Neurology|2009|581